{"id":4697,"date":"2021-12-18T06:37:37","date_gmt":"2021-12-18T06:37:37","guid":{"rendered":"https:\/\/www.cornerstone.com\/?post_type=article&p=4697"},"modified":"2024-08-27T19:41:38","modified_gmt":"2024-08-28T00:41:38","slug":"evaluating-innovation-theories-of-harm-in-merger-review-economic-frameworks-and-difficulties","status":"publish","type":"article","link":"https:\/\/www.cornerstone.com\/insights\/articles\/evaluating-innovation-theories-of-harm-in-merger-review-economic-frameworks-and-difficulties\/","title":{"rendered":"Evaluating Innovation Theories of Harm in Merger Review: Economic Frameworks and Difficulties"},"content":{"rendered":"","protected":false},"featured_media":0,"template":"","categories":[47,65,59,113],"tags":[25],"asset_type":[32],"class_list":["post-4697","article","type-article","status-publish","hentry","category-antitrust-and-competition","category-life-sciences","category-merger-litigation","category-merger-review","tag-europe"],"acf":[],"yoast_head":"\n